- IHH Healthcare’s ACE framework drives growth through three pillars: align, challenge and empower. It focuses on aligning operations with its mission, challenging the organisation to innovate and improve efficiencies, and empowering localised growth in each key market. Earnings growth appears decent but valuations do not appear attractive to other non-cyclical stocks.
- - Read this at SGinvestors.io -
Optimising Singapore.
- As the government will not be awarding new private hospital licences in Singapore, IHH is looking to expand across the healthcare continuum. This includes two ambulatory care centres (ACC) and 15 primary care clinics by 2028 to complement its current portfolio of four hospitals, two ACCs, and 50+ clinics.
- - Read this at SGinvestors.io -
- Additionally, the retrofitting of Mount Novena and investment in advanced medical technologies, such as photon therapy, to provide cutting-edge care will lift revenue intensity in a relatively mature and saturated market.
Exciting growth in store for Malaysia.
- Read more at SGinvestors.io.
Above is the excerpt from report by UOB Kay Hian Research.
Clients of UOB Kay Hian may be the first to access the full report in PDF @ https://www.utrade.com.sg/.
Philip Wong UOB Kay Hian Research | https://research.uobkayhian.com/ 2024-10-15
Previous report by UOB:
2023-12-01 IHH Healthcare - All Segments Largely Delivered In 3Q23.
Price targets by other brokers at IHH Healthcare Target Prices.
Listing of research reports at IHH Healthcare Analyst Reports.
Relevant links:
IHH Healthcare Share Price History,
IHH Healthcare Announcements,
IHH Healthcare Dividends & Corporate Actions,
IHH Healthcare News Articles
